U.S. Food Stock News

Colgate-Palmolive (NYSE:CL) and its subsidiary Tom's of Maine have agreed to a class action settlement related to alleged deceptive marketing of certain Tom's toothpaste products. The settlement establishes a US$2.9 million fund to compensate eligible consumers who purchased the products at issue. The agreement resolves multiple ongoing legal actions without Colgate-Palmolive or Tom's of Maine admitting wrongdoing. For you as an investor, this legal development sits within a broader...

High profile NFL reporter Dianna Russini resigned from New York Times subsidiary The Athletic following an internal investigation into her conduct. A separate court decision dismissed a major libel case brought by Donald Trump, which, while not directly targeting New York Times, could influence future media litigation. New York Times, NYSE:NYT, enters this news cycle with its share price at $81.1 and a value score of 2. The stock has logged a 16.2% return year to date and a 68.2% return...

Qnity Electronics (NYSE:Q) has opened a new semiconductor manufacturing facility in Newark, Delaware focused on advanced components for AI chip production. The company has also acquired a semiconductor facility in Taiwan to support next generation chip manufacturing. These moves expand Qnity Electronics' production footprint across the US and Asia in advanced semiconductor applications. For investors watching the AI hardware supply chain, Qnity Electronics now has a larger physical base...

Signet Jewelers (NYSE:SIG) reported its largest ever single-year fundraising total for St. Jude Children's Research Hospital. The company highlighted this record figure as a milestone in its long-running partnership with the hospital. The announcement underscores Signet's focus on social responsibility alongside its core jewelry retail operations. As the largest specialty jewelry retailer in the U.S., Signet operates brands many consumers recognize from malls and online shopping. The...

Wondering if V2X at around US$68.83 is offering value or asking you to pay up? This article breaks down what the current price really implies. The stock has seen mixed short term moves, with a 2.5% decline over the last 7 days, a 2.5% gain over the last 30 days, and returns of 23.9% year to date and 42.0% over the past year. Recent attention on V2X has focused on its role within the Aerospace & Defense sector and how its contract profile and government exposure fit into broader investor...

We'd be surprised if Porch Group, Inc. ( NASDAQ:PRCH ) shareholders haven't noticed that the Chief Operating Officer...

Modine Manufacturing (NYSE:MOD) has created a dedicated Data Centers division and appointed Art Laszlo as President. The company plans to spin off its Performance Technologies segment to focus on its data center cooling business. These corporate changes aim to align the business more closely with demand for data center focused solutions. For investors tracking NYSE:MOD, these moves come with the shares at $238.14 and substantial multi year gains, including about 20.3% over the past 30 days...

If you are wondering whether Ocular Therapeutix at around US$8.91 is priced attractively or already reflecting a lot of optimism, starting with a clear look at value can help you frame that question. The stock has seen a mix of moves, with a 5.8% gain over the last 7 days, a 3.2% return over the past month, a 24.3% gain over 1 year, set against a 24.6% decline year to date and a 41.7% decline over 5 years. Over the past year, headlines have focused on Ocular Therapeutix as a specialist in...

Owens Corning (NYSE:OC) has amended its agreement to sell its glass reinforcements business to Praana Group. The revised terms are intended to streamline Owens Corning's exit from this operation and increase immediate cash realization. The move marks a shift away from more capital intensive activities within the portfolio. For investors tracking Owens Corning at a share price of $116.58, this transaction update comes after mixed multi year returns, with the stock up 22.1% over 3 years and...

At a special meeting held on April 2, 2026, Black Hills Corporation shareholders approved amendments to the company’s restated articles of incorporation. This governance change could influence how the utility manages future corporate structure and decision-making, drawing fresh attention from investors assessing its long-term direction. Next, we’ll examine how the amended articles of incorporation might influence Black Hills’ investment narrative and future governance-driven...

If you are asking whether Steel Dynamics at US$194.11 still offers value or is pricing in too much optimism, the starting point is to look closely at how its current share price lines up with different valuation checks. The stock has returned 3.5% over the past 7 days, 11.4% over 30 days, 10.3% year to date, and 67.8% over 1 year, which naturally raises questions about what is already reflected in the price. Recent coverage has focused on Steel Dynamics as a key name in US-listed steel...

The United States market has shown robust performance, with a 3.4% increase over the last week and a remarkable 35% rise over the past year, while earnings are projected to grow by 16% annually. In such an environment, identifying stocks that may be undervalued can provide opportunities for investors seeking potential value plays amidst rising market trends.

The United States market has shown robust performance, rising 3.4% over the last week and an impressive 35% over the past year, with earnings expected to grow by 16% annually. In such a thriving environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business.

The United States market has shown robust performance, rising 3.4% over the last week and 35% over the past year, with earnings projected to grow by 16% annually. In such a thriving market, identifying stocks with strong potential for growth often involves looking beyond well-known names to those that might not be on every investor's radar. Penny stocks, though an older term, remain relevant as they often represent smaller or newer companies that could offer surprising value and stability...

NioCorp Developments (NasdaqGM:NB) recently announced a non binding term sheet with Traxys North America LLC that outlines an extensive marketing and offtake framework for critical minerals from its Elk Creek Project. See our latest analysis for NioCorp Developments. The Traxys term sheet arrives after a sharp shift in sentiment, with the share price up 18.44% in the last day and a 1 year total shareholder return of 55.94% despite a weaker 90 day share price return. Recent momentum appears to...

The United States market has experienced a notable upswing, rising 3.4% over the last week and climbing 35% in the past year, with earnings projected to grow by 16% annually. In this thriving environment, identifying stocks with strong fundamentals and growth potential can be key to uncovering hidden opportunities that align with these positive trends.

If you are wondering whether Kohl's current share price reflects its underlying value, the recent track record gives you plenty to think about. The stock last closed at US$14.30, with returns of 5.8% over 7 days, 9.7% over 30 days, a 33.0% decline year to date, and 141.9% over 1 year. These moves sit against an ongoing debate about how investors should view traditional department store retailers and the role of physical stores in a more digital shopping world. Sector headlines around...

Wondering whether Praxis Precision Medicines at US$339.93 is priced for its future potential or already reflecting high expectations? This article breaks down what the current share price could mean for you. The stock has recent returns of 6.2% over 7 days, 11.5% over 30 days and 18.7% year to date, with a very large 1 year return that is more than 10x. Recent coverage of Praxis Precision Medicines has focused on its position in the biotech space and how sentiment around its pipeline and...

ANI Pharmaceuticals (NasdaqGM:ANIP) has launched Carbamazepine Extended-Release Capsules, a limited competition generic version of Carbatrol. The company also reported publication of Phase 4 clinical trial results for ILUVIEN in a leading ophthalmology journal. These updates expand ANI's presence in specialty generics and reinforce its role in high-value therapeutic areas. ANI Pharmaceuticals enters this news cycle with its shares at $76.48 and a 1 year return of 10.5%. Over the past 3...

Latest Quarter Sets the Stage for Wells Fargo's Earnings Story Wells Fargo (WFC) opened 2026 with Q1 revenue of US$20.3b and basic EPS of US$1.62, against a trailing twelve month EPS of US$6.55 and net income of US$20.7b, giving investors a clear read on both the quarter and the broader earnings run rate. Over recent periods, revenue has moved from US$19.3b in Q4 2024 to US$19.2b in Q1 2025 and US$20.3b in Q1 2026, while quarterly EPS has shifted from US$1.45 to US$1.41 and now US$1.62. This...

Bitmine Immersion Technologies (BMNR) has stepped into Q2 2026 with Q1 figures that put its earnings profile front and center, posting total revenue of US$2.3 million and a basic EPS loss of US$15.98, alongside a net loss of about US$5.2 billion excluding extra items. Over the past year, the company has seen quarterly revenue move from US$0.7 million in Q4 2024 to US$1.2 million in Q1 2025 and US$2.3 million in Q1 2026. Over the same period, EPS has swung from a loss of US$0.33 in Q4 2024 to...

Credit Acceptance is drawing attention for sluggish growth and a relatively high debt load. Recent analysis points to stagnating revenue and earnings over the long term, raising questions about profit generation. These concerns focus on the company’s ability to comfortably service its borrowings and sustain shareholder value. For investors tracking NasdaqGS:CACC, the discussion around growth and leverage comes at a time when the stock trades at $497.36, with a 7 day return of 6.4% and a 30...

Over the last 7 days, the United States market has risen by 3.4%, contributing to a remarkable 35% increase over the past year, with earnings forecasted to grow by 16% annually. In this buoyant environment, identifying stocks that are potentially undervalued yet exhibit insider action can be an intriguing strategy for investors seeking opportunities within the small-cap segment.

The United States market has shown robust growth, rising 3.4% over the last week and climbing 35% in the past year, with earnings projected to increase by 16% annually. In such a thriving environment, identifying undervalued stocks can present opportunities for investors seeking to capitalize on potential gains while navigating current market conditions.